SmallJGMilsteinVMedlockCEClinical EEG findings in mania. Clin Electroencephalogr1997; 28:229–235.
2.
ShagassCRoemerRAStraumanisJJRelationships between psychiatric diagnosis and some quantitative EEG variables. Arch Gen Psychiat1982; 39: 1423–1435.
3.
ShagassCRoemerRAStraumanisJJJosiassenRCPsychiatric diagnostic discriminations with combinations of quantitative EEG variables. Br J Psychiat1984; 144: 581–592.
4.
GerezMTelloA.Clinical significance of focal topographic changes in the electroencephalogram (EEG) and evoked potentials (EP) of psychiatric patients. Brain Topogr1992; 5: 3–10.
5.
KanoKNakamuraMMatsuokaTLidaHNakajimaT.The topographical features of EEGs in patients with affective disorders. Electroencephalogr Clin Neurophysiol1992; 83: 124–129.
6.
KolesZJLindJCFlor-HenryP.Spatial patterns in the background EEG underlying mental disease in man. Electroencephalogr Clin Neurophysiol1994; 91: 319–328.
7.
SmallJGSmallIFPerezHCEEG, CNV, and evoked potential variations with lithium in manic depressive disease. Biol Psychiat1971; 3: 47–58.
8.
SmallJGMilsteinVPerezHCSmallIFMooreDFEEG and neurophysiological studies of lithium in normal volunteers. Biol Psychiat1972; 5: 65–77.
9.
BenteDScheulerWUlrichGMuller-OerlinghausenB.Effects of lithium on the EEG of healthy subjects and psychiatric patients: Methods, results and hypotheses. In: HerrmannW (ed). EEG in Drug Research. New York: Gustav Fischer; 1982: 369–385.
10.
UlrichGHerrmannWMHegerUMuller-OerlinghausenB.Effect of lithium on the dynamics of electroencephalographic vigilance in healthy subjects. J Affect Disord1990; 20: 19–25.
11.
SmallJGMilsteinVKellamsJJMillerMJBoykoOBSmallIFEEG topography in psychiatric diagnosis and drug treatment. Ann Clin Psychiat1989; 1: 7–17.
12.
PrienRFCaffeyEMKlettCJComparison of lithium carbonate and chlorpromazine in the treatment of mania. Arch Gen Psychiat1972; 26: 146–215.
13.
PrienRFKupferDFManskyPADrug therapy in the prevention of recurrences in unipolar and bipolar affective disorders. Arch Gen Psychiat1984; 41: 1096–1104.
14.
SmallJGKlapperMHKellamsJJElectroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiat1988; 45: 727–732.
15.
SmallJGKlapperMHMilsteinVCarbamazepine compared with lithium in the treatment of mania. Arch Gen Psychiat1991; 48: 915–921.
16.
SmallJGKlapperMHMarhenkeJDMilsteinVWoodhamGCKellamsJJLithium combined with carbamazepine or haloperidol in the treatment of mania. Psychopharmacol Bull1995; 31: 265–272.
17.
SmallJGKlapperMHMilsteinVMarhenkeJDSmallIFComparison of therapeutic modalities for mania. Psychopharmacol Bull1996; 32: 623–627.
18.
BowdenCLBruggerAMSwannACEfficacy of Divalproex vs. lithium and placebo in the treatment of mania. JAMA1994; 271: 918–924.
19.
SpitzerRLFrom Feighner to RDC, DSM-III, DSM-III-R, DSM-IV and ICD-10. In: The Feighner Criteria: Their role in Psychiatric Progress. 25th Anniversary Review. Secaucus, NJ: Churchill Communications North America, Inc.; 1997: 11–13.
20.
SmallJGMilsteinVSmallIFMillerMJKellamsJJComputerized EEG profiles of haloperidol, chlorpromazine, clozapine, and placebo in treatment resistant schizophrenia. Clin Electroencephalogr1987; 18: 124–135.
21.
SmallJGMilsteinVKellamsJJMillerMJBoykoOBSmallIFEEG topography in psychiatric diagnosis and drug treatment. Ann Clin psychiat1989; 1: 7–17.
22.
HartwellJWEEGSYS User Guide. V.5.2. Baltimore, MD: Friends Medical Science Research Center, Inc., 1994.
23.
YoungRCBiggsJTZieglerVEMeyerDAA rating scale for mania: Reliability, validity and sensitivity. Br J Psychiat1978; 133: 429–435.
24.
GuyW.ECDEU Assessment Manual for Psychopharmacology, revision 2. US Dept of Health, Education, and Welfare publication (ADM) 76–338. Washington, D.C.: US Dept of Health, Education, and Welfare, 1976.
25.
KnottVJTelnerJILapierreYDBrowneMHornERQuantitative EEG in the prediction of antidepressant response to imipramine. J Affect Disord1996; 39: 175–184.
26.
NormanRMGMallaAKWilliamsonPCMorrison-StewartSLHelmesECorteseL.EEG Coherence and syndromes in schizophrenia. Br J Psychiat1997; 170: 411–415.
27.
FordMRGoetheJWDekkerDKEEG coherence and power in the discrimination of psychiatric disorders and medication effects. Biol Psychiat1986; 21: 1175–1188.
28.
MerrinELFloydTCFeinG.EEG coherence in unmedicated schizophrenic patients. Biol Psychiat1989; 25: 60–66.
29.
NagaseYOkuboYMatsuuraMKohimaTToruM.EEG coherence in unmedicated schizophrenic patients: Topographical study of predominantly never medicated cases. Biol Psychiat1992; 32: 1028–1034.
30.
GelenbergA.New anticonvulsants in bipolar and other psychiatric disorders. Biol Therapies Psychiatry Newsletter1997; 20: 21–24.